Skip to Main content Skip to Navigation
Journal articles

ImmunoPET in Multiple Myeloma—What? So What? Now What?

Abstract : Despite constant progress over the past three decades, multiple myeloma (MM) is still an incurable disease, and the identification of new biomarkers to better select patients and adapt therapy is more relevant than ever. Recently, the introduction of therapeutic monoclonal antibodies (mAbs) (including direct-targeting mAbs and immune checkpoint inhibitors) appears to have changed the paradigm of MM management, emphasizing the opportunity to cure MM patients through an immunotherapeutic approach. In this context, immuno-positron emission tomography (immunoPET), combining the high sensitivity and resolution of a PET camera with the specificity of a radiolabelled mAb, holds the capability to cement this new treatment paradigm for MM patients. It has the potential to non-invasively monitor the distribution of therapeutic antibodies or directly monitor biomarkers on MM cells, and to allow direct observation of potential changes over time and in response to various therapeutic interventions. Tumor response could, in the future, be anticipated more effectively to provide individualized treatment plans tailored to patients according to their unique imaging signatures. This work explores the important role played by immunotherapeutics in the management of MM, and focuses on some of the challenges for this drug class and the significant interest of companion imaging agents such as immunoPET.
Document type :
Journal articles
Complete list of metadatas

Cited literature [116 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02881836
Contributor : Elizabeth Bernardo <>
Submitted on : Friday, June 26, 2020 - 9:39:23 AM
Last modification on : Wednesday, July 15, 2020 - 1:30:04 PM

File

cancers-12-01467-v2.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Clément Bailly, Benjamin Chalopin, Sébastien Gouard, Thomas Carlier, Patricia Remaud-Le Saec, et al.. ImmunoPET in Multiple Myeloma—What? So What? Now What?. Cancers, MDPI, 2020, 12 (6), pp.1467. ⟨10.3390/cancers12061467⟩. ⟨inserm-02881836⟩

Share

Metrics

Record views

43

Files downloads

70